ArticleJournal of gastroenterology2020

Proteomics analysis identified TPI1 as a novel biomarker for predicting recurrence of intrahepatic cholangiocarcinoma.

Wen-Long Yu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.